Free Trial

UNIVEST FINANCIAL Corp Sells 9,768 Shares of MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Key Points

  • UNIVEST FINANCIAL Corp has reduced its stake in MetLife by 24.9%, selling 9,768 shares and now holding 29,535 shares worth approximately $2.37 million.
  • MetLife is receiving positive assessments from analysts, with price targets typically between $94.00 and $98.00, reflecting an overall rating of "Moderate Buy."
  • The company is set to pay a quarterly dividend of $0.5675 per share on September 9th, representing a yield of 3.0%.
  • Five stocks we like better than MetLife.

UNIVEST FINANCIAL Corp lessened its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 24.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 29,535 shares of the financial services provider's stock after selling 9,768 shares during the period. UNIVEST FINANCIAL Corp's holdings in MetLife were worth $2,371,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in MET. Ball & Co Wealth Management Inc. purchased a new position in shares of MetLife during the 4th quarter worth $25,000. Transce3nd LLC bought a new position in MetLife in the 4th quarter worth $26,000. North Capital Inc. purchased a new position in MetLife during the first quarter valued at $26,000. Quarry LP bought a new stake in MetLife during the fourth quarter valued at about $31,000. Finally, Motco increased its position in MetLife by 105.5% in the first quarter. Motco now owns 413 shares of the financial services provider's stock worth $33,000 after buying an additional 212 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company's stock.

Wall Street Analysts Forecast Growth

MET has been the subject of a number of recent research reports. Barclays boosted their price objective on MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research note on Monday, July 7th. Morgan Stanley reissued an "overweight" rating and issued a $98.00 price objective (down from $99.00) on shares of MetLife in a research note on Monday, July 14th. Wall Street Zen downgraded shares of MetLife from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Keefe, Bruyette & Woods dropped their target price on shares of MetLife from $95.00 to $94.00 and set an "outperform" rating for the company in a report on Wednesday, July 9th. Finally, Wells Fargo & Company reissued an "overweight" rating and set a $97.00 price target (up from $94.00) on shares of MetLife in a report on Thursday, July 10th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, MetLife presently has an average rating of "Moderate Buy" and an average target price of $96.09.

View Our Latest Analysis on MET

MetLife Trading Up 1.6%

Shares of MET stock opened at $75.96 on Friday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $50.99 billion, a price-to-earnings ratio of 12.35, a price-to-earnings-growth ratio of 0.61 and a beta of 0.85. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The stock's 50-day moving average price is $78.46 and its 200-day moving average price is $79.55.

MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.00 by ($0.04). The firm had revenue of $18.57 billion during the quarter, compared to the consensus estimate of $18.06 billion. MetLife had a return on equity of 20.89% and a net margin of 6.08%. The business's revenue was up 15.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.83 EPS. Equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife declared that its Board of Directors has approved a share repurchase program on Wednesday, April 30th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to repurchase up to 5.9% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's leadership believes its stock is undervalued.

MetLife Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be given a dividend of $0.5675 per share. The ex-dividend date is Tuesday, August 5th. This represents a $2.27 annualized dividend and a yield of 3.0%. MetLife's dividend payout ratio (DPR) is 36.91%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Institutional Ownership by Quarter for MetLife (NYSE:MET)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines